Loading
IARC estimates 13,064 new cancer cases and 6,210 cancer deaths in Paraguay in 2024; the commonest new cancers are prostate, breast and cervix uteri. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Prostate | 2,103 | 72.0 | Prostate cancer |
| Breast | 1,877 | 52.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 1,121 | 30.9 | Cervical cancer |
| Colorectum | 1,112 | 16.4 | Colorectal cancer |
| Trachea, bronchus and lung | 786 | 11.9 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Thyroid | 506 | 7.3 | Thyroid cancer |
| Stomach | 408 | 6.0 | Gastric & gastro-oesophageal junction cancer |
| Non-Hodgkin lymphoma | 360 | 5.3 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Leukaemia | 344 | 5.1 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Pancreas | 329 | 4.9 | Pancreatic ductal adenocarcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 702 | 10.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Breast | 631 | 17.6 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 601 | 21.1 | Prostate cancer |
| Cervix uteri | 593 | 16.5 | Cervical cancer |
| Colorectum | 578 | 8.6 | Colorectal cancer |
| Pancreas | 318 | 4.8 | Pancreatic ductal adenocarcinoma |
| Stomach | 299 | 4.5 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 241 | 3.6 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Liver and intrahepatic bile ducts | 202 | 3.1 | Hepatocellular carcinoma |
| Oesophagus | 173 | 2.7 | Oesophageal cancer |
No trial record in OnCo lists a site in Paraguay. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Paraguay.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Paraguay is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Paraguay is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.